Delivery Order SPE2DB22D3010-SPE2DB25FP3MA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,203.06 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price contract, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency awarded a $27,880.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 5, 2025. This non-competitive delivery order represents a firm fixed-price purchase under the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran...
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,793.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $13,248.86 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick autoinjectors, with performance in Conshohocken, Pennsylvania and completion by August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. This delivery order falls under...
- The Defense Logistics Agency awarded a $44,398.54 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This competitive, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $41,877.63 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens under a firm fixed price contract type. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction. This delivery order constitutes a...
- The Defense Logistics Agency awarded a $41,766.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), carries an ultimate completion date of August 22, 2025. This award was competitively granted with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,270.22 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $3,761.28 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating competitive procurement. AmerisourceBergen,...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3MADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,573.95 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX, running through December 2026), which enables the company to supply a broad range of pharmaceutical products and medical supplies globally in support of military healthcare programs. Repatha is a PCSK9 inhibitor used for cardiovascular disease management, reflecting the therapeutic diversity of medications available through the prime vendor arrangement. The award demonstrates AmerisourceBergen's continued capacity to fulfill federal pharmaceutical supply requirements while supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 9/12/25 |